Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: GSK

HEALTH-CORONAVIRUS/BRITAIN
RTX7H5O6
May 04, 2020
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs
HEALTH-CORONAVIRUS/BRITAIN
RTX7H5O4
May 04, 2020
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs
GSK-RESULTS/
RTX7AKVN
November 26, 2019
A scientist studies cancer cells inside white blood cells through a microscope at the GlaxoSmithKline...
STEVENAGE, United Kingdom
A scientist studies cancer cells inside white blood cells through a microscope at the GSK research centre...
A scientist studies cancer cells inside white blood cells through a microscope at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKVJ
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKVG
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKVA
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV9
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV7
November 26, 2019
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV6
November 26, 2019
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV5
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV4
November 26, 2019
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV3
November 26, 2019
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV2
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV1
November 26, 2019
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
Scientists look at test tubes containing stem cells at the GSK research centre in Stevenage
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKUX
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKUR
November 26, 2019
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
Scientists look at test tubes containing stem cells at the GSK research centre in Stevenage
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKUP
November 26, 2019
A GSK logo is seen on a flag at a GlaxoSmithKline (GSK) research centre in Stevenage, Britain November...
STEVENAGE, United Kingdom
A GSK logo is seen on a flag at a GSK research centre in Stevenage
A GSK logo is seen on a flag at a GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKSX
November 26, 2019
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019....
STEVENAGE, United Kingdom
A GSK logo is seen at the GSK research centre in Stevenage
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKSP
November 26, 2019
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019....
STEVENAGE, United Kingdom
A GSK logo is seen at the GSK research centre in Stevenage
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKRP
November 26, 2019
A scientist prepares stem cells for research at the GSK research centre in Stevenage, Britain November...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKRG
November 26, 2019
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKRF
November 26, 2019
A scientist prepares stem cells for research at the GSK research centre in Stevenage, Britain November...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-CONSUMER HEALTH/
RTS2GB9X
April 04, 2019
Brian McNamara, CEO of GSK Consumer Healthcare, poses for a picture at the companyÕs office in London,...
London, United Kingdom
Brian McNamara, CEO of GSK Consumer Healthcare, poses for a picture at the companyÕs office in London...
Brian McNamara, CEO of GSK Consumer Healthcare, poses for a picture at the companyÕs office in London, Britain April 4, 2019. REUTERS/Martinne Geller
BRITAIN-EU/
RTX6G1C7
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BS
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BP
October 22, 2018
GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley tours GSK's new production building in Montrose, Scotland,...
MONTROSE, United Kingdom
GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley tours GSK's new production building in Montrose, Scotland...
GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley tours GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BK
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BD
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BB
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
SINGAPORE-PHARMACEUTICALS/
RTX5CFOE
March 25, 2018
A general view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken...
Singapore, Singapore
A general view of GlaxoSmithKline (GSK) Asia House is seen in Singapore
A general view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFO9
March 25, 2018
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore, March 21, 2018. Picture taken...
Singapore, Singapore
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFNY
March 25, 2018
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture...
Singapore, Singapore
The GSK logo is seen on top of GSK Asia House in Singapore
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFNU
March 25, 2018
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture...
Singapore, Singapore
The GSK logo is seen on top of GSK Asia House in Singapore
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFNQ
March 25, 2018
An aerial view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken...
Singapore, Singapore
An aerial view of GSK Asia House is seen in Singapore
An aerial view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFNM
March 25, 2018
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore, March 21, 2018. Picture taken...
Singapore, Singapore
A SMRT train travels past GSK Asia House in Singapore
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFMP
March 25, 2018
The GlaxoSmithKline (GSK) logo on top of GSK Asia House is seen through vertical louvres in Singapore,...
Singapore, Singapore
The GSK logo on the facade of GSK Asia House is seen through vertical louvres in Singapore
The GlaxoSmithKline (GSK) logo on top of GSK Asia House is seen through vertical louvres in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFMD
March 25, 2018
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture...
Singapore, Singapore
The GSK logo is seen on top of GSK Asia House in Singapore
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFM9
March 25, 2018
An exterior view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken...
Singapore, Singapore
An exterior view of GSK Asia House is seen in Singapore
An exterior view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFM6
March 25, 2018
An aerial view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken...
Singapore, Singapore
An aerial view of GSK Asia House is seen in Singapore
An aerial view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
GSK-CEO/
RTX3ICS3
October 26, 2017
GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London,...
London, United Kingdom
GlaxoSmithKline CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London
GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London, Britain, October 9, 2017. Picture taken October 9, 2017. REUTERS/Toby Melville
BRITAIN-EU/BUSINESS
RTS1FQOY
October 09, 2017
GlaxoSmithKline (GSK) CEO, Emma Walmsley, and Vodafone CEO Vittorio Colao, arrive for a meeting in Downing...
London, United Kingdom
GlaxoSmithKline CEO, Emma Walmsley, and Vodafone CEO Vittorio Colao, arrive for a meeting in Downing...
GlaxoSmithKline (GSK) CEO, Emma Walmsley, and Vodafone CEO Vittorio Colao, arrive for a meeting in Downing Street in central London, Britain October 9, 2017. REUTERS/Toby Melville
BRITAIN-EU/BUSINESS
RTS1FQJZ
October 09, 2017
GlaxoSmithKline (GSK) CEO, Emma Walmsley, carries documents as she arrives for a meeting in Downing Street...
London, United Kingdom
GlaxoSmithKline CEO, Emma Walmsley, carries documents as she arrives for a meeting in Downing Street...
GlaxoSmithKline (GSK) CEO, Emma Walmsley, carries documents as she arrives for a meeting in Downing Street in central London, Britain October 9, 2017. REUTERS/Toby Melville
BRITAIN-EU/BUSINESS
RTS1FQJW
October 09, 2017
GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London,...
London, United Kingdom
GlaxoSmithKline CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London
GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London, Britain October 9, 2017. REUTERS/Toby Melville
GSK-BRITAIN/
RTSJU9E
July 27, 2016
A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby...
London, United Kingdom
File photo of a GlaxoSmithKline logo outside one of its buildings in west London
A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville/File Photo
GSK-BRITAIN/
RTSJU9D
July 27, 2016
The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor/File...
London, United Kingdom
The GlaxoSmithKline building is pictured in Hounslow, west London
The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor/File Photo
GSK-BRITAIN/
RTSJU5X
July 27, 2016
A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby...
London, United Kingdom
File photo of a GlaxoSmithKline logo outside one of its buildings in west London
A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville/File Photo
GSK-RESULTS/
RTSJGDD
July 25, 2016
The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor/File...
London, United Kingdom
The GlaxoSmithKline building is pictured in Hounslow, west London
The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor/File Photo RTX11R3W GLOBAL BUSINESS WEEK AHEAD PACKAGE - SEARCH "BUSINESS WEEK AHEAD JULY 25" FOR ALL IMAGES
GSK-ADVAIR/ C
RTX2FIAJ
June 03, 2016
GlaxoSmithKline’s top-selling lung drug Advair is now facing generic competition after the drug lost...
Rise and fall of Advair EPS C
GlaxoSmithKline’s top-selling lung drug Advair is now facing generic competition after the drug lost patent protection.
GSK-MOVES/CEO
RTX2CX1R
May 05, 2016
The GlaxoSmithKline building is pictured in Hounslow, west London, Britain, June 18, 2013. REUTERS/Luke...
London, United Kingdom
The GlaxoSmithKline building in Hounslow, west London
The GlaxoSmithKline building is pictured in Hounslow, west London, Britain, June 18, 2013. REUTERS/Luke MacGregor/File Photo
WITTY-MILKEN/
RTX2CIL8
May 03, 2016
Andrew Witty, CEO of GlaxoSmithKline, speaks at the Milken Institute Global Conference in Beverly Hills,...
Beverly Hills, UNITED STATES
Andrew Witty, CEO of GlaxoSmithKline, speaks at the Milken Institute Global Conference in Beverly Hills...
Andrew Witty, CEO of GlaxoSmithKline, speaks at the Milken Institute Global Conference in Beverly Hills, California, U.S., May 2, 2016. REUTERS/Lucy Nicholson
GSK-UMBILICAL/
RTX2C57R
April 29, 2016
The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor/File...
London, United Kingdom
The GlaxoSmithKline building is pictured in Hounslow, west London
The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor/File Photo
GSK-RESULTS/
RTX2BU1Y
April 27, 2016
The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor/File...
London, United Kingdom
The GlaxoSmithKline building is pictured in Hounslow, west London
The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor/File Photo
GLAXOSMITHKLINE-RESULTS/
RTX2BGT5
April 25, 2016
Signage for GlaxoSmithKline is seen on it's offices in London, Britain, March 30, 2016. REUTERS/Toby...
London, United Kingdom
Signage for GlaxoSmithKline is seen on it's offices in London, Britain
Signage for GlaxoSmithKline is seen on it's offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo GLOBAL BUSINESS WEEK AHEAD PACKAGE - SEARCH 'BUSINESS WEEK AHEAD APRIL 25' FOR ALL IMAGES
GSK-PATENTS/
RTSCZ4Y
March 31, 2016
The GlaxoSmithKline building is pictured in Hounslow, west London, Britain, in this June 18, 2013 file...
London, United Kingdom
File photo of the GlaxoSmithKline building in Hounslow, west London
The GlaxoSmithKline building is pictured in Hounslow, west London, Britain, in this June 18, 2013 file photo. REUTERS/Luke MacGregor/Files
GSK-CHINA/ C
RTX1VWAQ
November 26, 2015
GSK-CHINA/ - Chart showing slowed growth of multinational corporations in China's pharmaceutical market....
China
GSK-CHINA/ C
GSK-CHINA/ - Chart showing slowed growth of multinational corporations in China's pharmaceutical market. (SIN03)
GSK-CHINA/
RTX1VVWO
November 26, 2015
Herve Gisserot, general manager for GSK China, poses for a photograph in front of a company logo during...
Shanghai, China
Herve Gisserot, general manager for GSK China, poses for a photograph in front of a company logo during...
Herve Gisserot, general manager for GSK China, poses for a photograph in front of a company logo during an interview with Reuters at an office in Shanghai, China, November 25, 2015. GlaxoSmithKline Plc has cut 40 percent of its sales reps in China and axed some units as it eyes a return to growth in 2016, after sales plunged during a bribery scandal that landed it with a record $490 million fine in 2014. Picture taken November 25. To match Interview GSK-CHINA/ REUTERS/Ben Hirschler
GSK-MALARIA/VACCINE C
RTX1LV55
July 26, 2015
GSK-MALARIA/VACCINE - Map of countries with ongoing transmission ofMalaria, includes charts showing number...
United Kingdom
GSK-MALARIA/VACCINE C
GSK-MALARIA/VACCINE - Map of countries with ongoing transmission ofMalaria, includes charts showing number of cases and deaths. (SIN03)
BRITAIN-ROYALS/
RTR4DWP1
November 12, 2014
Britain's Catherine, Duchess of Cambridge speaks with wheelchair athlete Sheikh Sheikh during her visit...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge speaks with a wheelchair athlete during her visit to a SportsAid...
Britain's Catherine, Duchess of Cambridge speaks with wheelchair athlete Sheikh Sheikh during her visit to a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
BRITAIN-ROYALS/
RTR4DWOY
November 12, 2014
Britain's Catherine, Duchess of Cambridge attends a SportsAid workshop at the GlaxoSmithKline (GSK) Human...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge attends a SportsAid workshop at the GSK Human Performance Laboratory...
Britain's Catherine, Duchess of Cambridge attends a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
BRITAIN-ROYALS/
RTR4DWOU
November 12, 2014
Britain's Catherine, Duchess of Cambridge (L) speaks with young athlete Emma Allen during her visit to...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge speaks with young athlete during her visit to a SportsAid workshop...
Britain's Catherine, Duchess of Cambridge (L) speaks with young athlete Emma Allen during her visit to a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
Sort by
Display
Items per page
Page
of 3